Amaranthus retroflexus whole
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Summary
Amaranthus retroflexus whole is an extract from Amaranthus retroflexus whole used in allergy testing.
- Generic Name
- Amaranthus retroflexus whole
- DrugBank Accession Number
- DB10930
- Background
Amaranthus retroflexus whole allergenic extract is used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- Amaranthus bulgaricus whole
- Amaranthus bullatus whole
- Amaranthus curvifolius whole
- Amaranthus delilei whole
- Amaranthus johnstonii whole
- Amaranthus recurvatus whole
- Amaranthus retroflexus
- Amaranthus retroflexus whole
- Amaranthus rigidus whole
- Amaranthus spicatus whole
- Careless weed whole
- Galliaria retroflexa whole
- Galliaria scabra whole
- Red-root amaranth whole
- Redroot amaranth whole
- Redroot pigweed whole
- Rough pigweed whole
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Active Moieties
Name Kind UNII CAS InChI Key Amaranthus retroflexus pollen unknown 73B14PX5FW Not Available Not applicable - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Treatment Set TS345380 Amaranthus retroflexus whole (0.002 g/1mL) + Acer negundo pollen (0.002 g/1mL) + Ambrosia artemisiifolia pollen (160 [AU]/1mL) + Betula populifolia pollen (0.01 g/1mL) + Chenopodium album pollen (0.002 g/1mL) + Cynodon dactylon pollen (400 [BAU]/1mL) + Fraxinus americana pollen (0.0004 g/1mL) + Pascopyrum smithii pollen (0.002 g/1mL) + Plantago lanceolata pollen (0.002 g/1mL) + Populus deltoides pollen (0.002 g/1mL) + Quercus alba pollen (0.002 g/1mL) + Rumex acetosella pollen (0.004 g/1mL) + Sorghum halepense pollen (0.0004 g/1mL) + Ulmus americana pollen (0.0004 g/1mL) Injection, solution Intradermal; Subcutaneous Antigen Laboratories, Inc. 1986-10-31 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 55W4M8149I
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Intradermal; Subcutaneous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:04 / Updated at June 12, 2020 16:53